<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3376">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 18, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750265</url>
  </required_header>
  <id_info>
    <org_study_id>ROBEM II</org_study_id>
    <nct_id>NCT04750265</nct_id>
  </id_info>
  <brief_title>Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19</brief_title>
  <official_title>Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19: an Interventional Randomized, Controlled Feasibility Study (ROBEM II Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Reactive Robotics GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility trial investigating the potential higher frequency of robotic assisted early&#xD;
      mobilization in intubated COVID19 patients on the ICU.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 11, 2021</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, controlled, parallel-group, open label pilot trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of mobilization</measure>
    <time_frame>5 days</time_frame>
    <description>Level of mobilization during the first 5 days after admission on the ICU, measured with the ICU-Mobility Scale (0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of mobilization</measure>
    <time_frame>5 days</time_frame>
    <description>Level of mobilization during the first 5 days after admission on the ICU, measured with the Surgical Optimal Mobilization Scale (0-4)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of Mobilization</measure>
    <time_frame>5 days</time_frame>
    <description>Frequency of early mobilization during mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Initiation of first Mobilization</measure>
    <time_frame>5 days</time_frame>
    <description>Time of first mobilization after admission on ICU (in hours)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilization duration</measure>
    <time_frame>5 days</time_frame>
    <description>Average duration of mobilization sessions during mechanical ventilation (in min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depth of sedation</measure>
    <time_frame>5 days</time_frame>
    <description>Depth of sedation measured with RASS during the first 5 days after admission on ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of sedation</measure>
    <time_frame>during ICU stay (normally up to 30 days)</time_frame>
    <description>Days under sedative medication during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of mechanical ventilation</measure>
    <time_frame>during ICU stay (normally up to 30 days)</time_frame>
    <description>Days of mechanical ventilation during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of Intubation</measure>
    <time_frame>during ICU stay (normally up to 30 days)</time_frame>
    <description>Days of Intubation during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of Delirium</measure>
    <time_frame>during ICU stay (normally up to 30 days)</time_frame>
    <description>Days of Delirium during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRC Score</measure>
    <time_frame>One time point before ICU Discharge</time_frame>
    <description>MRC Score at ICU Discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle wasting</measure>
    <time_frame>5 days</time_frame>
    <description>Muscle wasting assessed using ultrasound measurement of the M. femoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Health care provider</measure>
    <time_frame>5 days</time_frame>
    <description>Number of Health care provider needed for mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>at 180 days after study start</time_frame>
    <description>Mortality during ICU and Hospital stay and 180 days after admission at ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Hospital stay (approx. 30 days)</time_frame>
    <description>Length of stay at ICU , in Hospital (in days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>at 180 days after study start</time_frame>
    <description>Global function measured with WHODAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care provider assessment</measure>
    <time_frame>5 days</time_frame>
    <description>Assessment of the satisfaction with the mobilization by the health care provider using Likert-Scales (1-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety events</measure>
    <time_frame>5 days after study start</time_frame>
    <description>Frequency of safety events during mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>at 180 days after study start</time_frame>
    <description>Measurement of ADLs/IADLs for which patients need assistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DRG workplace data</measure>
    <time_frame>Hospital stay (approx. 30 days)</time_frame>
    <description>expenses of the hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Covid19</condition>
  <condition>Critical Illness</condition>
  <condition>Critical Illness Polyneuromyopathy</condition>
  <condition>Early Mobilization</condition>
  <condition>Rehabilitation</condition>
  <condition>Robotics</condition>
  <arm_group>
    <arm_group_label>Robotic assisted early mobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early mobilization therapy assisted with robotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Mobilization according to standard care by staff</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robotic assisted early mobilization</intervention_name>
    <description>Robotic assisted early mobilization Robotic assisted early mobilization started within 72 hours of ICU admission.</description>
    <arm_group_label>Robotic assisted early mobilization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Invasive mechanically ventilated and expected to be ventilated for another 24 hours&#xD;
&#xD;
          -  Cardiovascular stability, allowing mobilization&#xD;
&#xD;
          -  Respiratory stability, allowing mobilization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not able to give consent&#xD;
&#xD;
          -  Bed-bound before ICU admission&#xD;
&#xD;
          -  Bed-rest order or contraindication of weight load of the lower extremity or spine&#xD;
&#xD;
          -  Severe skin lesions or fasciitis in the area of contact with the device or&#xD;
             rhabdomyolysis&#xD;
&#xD;
          -  Fresh SAB, ICB or elevated ICP&#xD;
&#xD;
          -  Status epilepticus&#xD;
&#xD;
          -  Acute intoxication&#xD;
&#xD;
          -  Shock with catecholamine doses &gt;0.3μg/kg/min or acute bleeding including organ&#xD;
             ruptures&#xD;
&#xD;
          -  Multiorgan failure with lactate &gt; 4 mmol/l&#xD;
&#xD;
          -  Body height outside the range 150-195 cm&#xD;
&#xD;
          -  Body weight outside the range 45-135 kg&#xD;
&#xD;
          -  pAVK IV°&#xD;
&#xD;
          -  Pacemakers or other electrical stimulators&#xD;
&#xD;
          -  Implanted medical pumps&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Life expectancy below 7 days or acute palliative care situation&#xD;
&#xD;
          -  Death inevitable or maximum therapy is not carried out by the treating physicians or&#xD;
             due to patient's request&#xD;
&#xD;
          -  Unable to understand the official language&#xD;
&#xD;
          -  ICU stay &gt; 72h at the time of enrolment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan J Schaller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan J Schaller, MD</last_name>
    <phone>+49-30-450-531052</phone>
    <email>stefan.schaller@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité - Univiversitätsmedizin Berlin</name>
      <address>
        <city>Berlin-Mitte</city>
        <state>Berlin</state>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan J Schaller, MD</last_name>
      <phone>+49-30-450-5311052</phone>
      <email>stefan.schaller@charite.de</email>
    </contact>
    <investigator>
      <last_name>Stefan J Schaller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Friedrich Kuhn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grunow Julius, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorenz Marco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 9, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Stefan J Schaller</investigator_full_name>
    <investigator_title>Deputy Clinical Director</investigator_title>
  </responsible_party>
  <keyword>COVID19</keyword>
  <keyword>Early mobilization</keyword>
  <keyword>robotics</keyword>
  <keyword>Vemo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Depersonalized data can be requested from the PI after publication of the study for scientific purpose.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After publishing results.</ipd_time_frame>
    <ipd_access_criteria>Data will be shared to other researchers on reasonable request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

